Arcutis Biotherapeutics Reports Third-Quarter Revenue of $143.9 Million
Story updates
09:03:37 PM UTC
SquawkNews
Arcutis reported third-quarter 2026 net product revenue of $143.9 million, up 45% year over year, and net income of $8.8 million. The company generated $18.9 million in operating cash flow and raised its full-year 2026 net product sales guidance to $535 million—$545 million.Financial HighlightsBusi…
09:03:42 PM UTC
SquawkNews
*-- Earnings Flash (ARQT) Arcutis Biotherapeutics, Inc. Reports Q3 Revenue $143.9M, vs.
09:15:44 PM UTC
SquawkNews
Arcutis Biotherapeutics Q3 product revenue rises 45% on ZORYVE demand